Actualités id6343.html
In development: Guidance, quality standards and advice
Sat, 25 Jan 2025 20:29:00 GMT
Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease [ID6343] Technology appraisal guidance TBC Ibrutinib for treating ...